Michael Gelband’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,637
Closed -$13.4K 1948
2025
Q4
$13.4K Buy
+10,637
New +$14.8K ﹤0.01% 1467
2025
Q2
Sell
-209,300
Closed -$347K 1847
2025
Q1
$347K Buy
209,300
+35,600
+20% +$58.6K ﹤0.01% 1204
2024
Q4
$255K Buy
+173,700
New +$266K ﹤0.01% 1321
2024
Q2
Sell
-23,351
Closed -$28K 1852
2024
Q1
$28K Sell
23,351
-242,479
-91% -$243K ﹤0.01% 1439
2023
Q4
$401K Buy
265,830
+253,741
+2,099% +$367K ﹤0.01% 1097
2023
Q3
$19K Buy
+12,089
New +$22K ﹤0.01% 1625
2022
Q4
Sell
-38,744
Closed -$73K 1992
2022
Q3
$73K Sell
38,744
-201,656
-84% -$477K ﹤0.01% 1773
2022
Q2
$608K Sell
240,400
-379,816
-61% -$1.11M 0.01% 1285
2022
Q1
$2.13M Sell
620,216
-161,929
-21% -$572K 0.03% 749
2021
Q4
$3.76M Buy
782,145
+345,531
+79% +$1.4M 0.04% 533
2021
Q3
$1.59M Sell
436,614
-207,744
-32% -$773K 0.02% 815
2021
Q2
$2.61M Buy
644,358
+535,376
+491% +$2.1M 0.03% 561
2021
Q1
$468K Buy
+108,982
New +$521K 0.01% 1417
2020
Q4
Sell
-184,669
Closed -$681K 2271
2020
Q3
$681K Buy
184,669
+123,509
+202% +$521K 0.01% 856
2020
Q2
$209K Buy
+61,160
New +$137K 0.01% 1496

Other funds holding OPK

Michael Gelband's OPK Position: Q1 2026 in Review

Michael Gelband sold out of Opko Health (OPK) in Q1 2026, closing a stake of 10,637 shares — an estimated $13.4K sold.

Michael Gelband first reported a position in OPK in Q2 2020 and held it in 15 quarters. The position peaked at $3.76M in Q4 2021. 236 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • Michael Gelband reported no remaining Opko Health position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 10,637 Opko Health shares in Q1 2026, an estimated $13.4K.
  • Michael Gelband first reported a position in Opko Health in Q2 2020 and held it in 15 quarters.
  • Michael Gelband's Opko Health position peaked at $3.76M in Q4 2021.
  • 236 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.